Cagrilintide is an investigational amylin-analog peptide currently in development for weight management applications. This synthetic peptide analog shows promise in clinical research for its potential effects on appetite regulation and metabolic function.
The compound works through multiple mechanisms including delayed gastric emptying, enhanced satiety signaling, and modulation of glucose metabolism. These properties make it a promising candidate for obesity research and metabolic disorder studies.
Our Cagrilintide powder is provided in lyophilized form with a minimum purity of 99.5% as verified by HPLC analysis. The material is suitable for research applications in controlled laboratory settings.
Key characteristics of this research material include:
- High purity pharmaceutical-grade peptide
- Lyophilized powder form for easy reconstitution
- Strict quality control testing
- Properly documented chain of custody
- Research use only - not for human consumption
Storage recommendations: Maintain at -20°C in dry conditions. Protect from light and moisture. When properly stored, the material remains stable for extended periods.
This product is intended for qualified researchers in controlled laboratory environments. Proper safety protocols should always be followed when handling research peptides.